Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2025PharmaceuticalsOpen Access

Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog

View Full Paper
Ask AI
Bookmark
Share

Authors

FGFabiana Sélos GuerraRFRosana Helena Coimbra Nogueira de FreitasFMFlorina Moldovan

Discussion

Loading...

Member takes

Overview

Design of vemurafenib analogs improved apoptosis and reduced metastasis in melanoma, suggesting a new anti-cancer strategy.

Key Points

  • Structural modifications to vemurafenib led to enhanced anti-proliferative activity in melanoma cells.
  • RF-86A analog showed the lowest IC50 value, indicating strong efficacy against BRAFV600E-mutated A375 cells.
  • The analogs significantly inhibited matrix metalloproteinases MMP-2 and MMP-9, reducing tumor invasion.
  • These findings highlight the potential of modified vemurafenib analogs to overcome resistance in melanoma treatment.

Cite This Study

Guerra et al. (2025) studied this question.

synapsesocial.com/papers/689521e49f4f1c896c42809fhttps://doi.org/10.3390/ph18081161
View Full Paper
Ask AI
Bookmark
Share